US FDA advisors back Pfizer COVID-19 vaccine for children ages 5 to 11

Children in the US could be vaccinated against COVID-19 as early as next week. A panel of Food and Drug Administration advisors have voted to recommend the use of Pfizer’s vaccine for children ages five to 11. The vote marks an important regulatory step toward reaching about 28 million children for inoculation. Pfizer said its vaccine showed 90.7% efficacy against the coronavirus of children aged five to 11. Pfizer is seeking clearance for a lower, 10-microgram dose of the vaccine in children, versus 30 micrograms for everyone over the age of 12. Subscribe to our channel here: Subscribe to our news service on Telegram: Follow us: CNA: CNA Lifestyle: Facebook: Instagram: Twitter: